SEP 16, 2018 7:49 PM PDT

Testosterone Replacement Therapy Slows Progression of Chronic Obstructive Pulmonary Disease

WRITTEN BY: Nouran Amin

According to the World Health Organization (WHO), by the year 2030 chronic obstructive pulmonary disease (COPD) will be internationally the third-leading cause of illness and death internationally by 2030. Men diagnosed with COPD will likely have low testosterone which may worsen their condition. Additionally, they may have shortness of breath and often take steroid-based therapeutics over an extended period of time-- increasing their risk of low testosterone.

In a study published in Chronic Respiratory Disease, researchers from The University of Texas Medical Branch at Galveston discovered that testosterone replacement therapy may reduce the progression of chronic obstructive pulmonary disease. "Previous studies have suggested that testosterone replacement therapy may have a positive effect on lung function in men with COPD," said Jacques Baillargeon, UTMB professor in preventive medicine and community health. "However, we are the first to conduct a large scale nationally representative study on this association."

Image via Lung Disease News

The purpose of the research study was to determine if testosterone replacement therapy decreased the risk of respiratory hospitalizations in middle-aged and older men with COPD. By utilizing ‘Clinformatics Data Mart,’ a database consisting of the largest commercially insured populations in the U.S., Baillargeon and colleagues examined data of 450 COPD male participants aged 40 to 63 with COPD who were placed on testosterone replacement therapy between 2005 and 2014. Additionally, the derived data from the National Medicare to examine information from 253 COPD males aged 66 and older who were on testosterone replacement therapy between 2008 and 2013. "We found that testosterone users had a greater decrease in respiratory hospitalizations compared with non-users. Specifically, middle-aged testosterone replacement therapy users had a 4.2 percent greater decrease in respiratory hospitalizations compared with non-users and older testosterone replacement therapy users had a 9.1 percent greater decrease in respiratory hospitalizations compared with non-users," said Baillargeon. "The findings suggest that testosterone replacement therapy may slow the progression of disease in men with COPD."

Source: Chronic Respiratory Disease via Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 25, 2020
Cannabis Sciences
APR 25, 2020
Researchers Trial Cannabis to Treat COVID-19
Researchers in Israel are investigating the potential for cannabis-derived products to treat patients with COVID-19. So ...
APR 26, 2020
Cell & Molecular Biology
APR 26, 2020
Researchers Remotely Trigger the Release of Hormones
It may one day be possible to treat hormone-related diseases using this method.
APR 26, 2020
Cell & Molecular Biology
APR 26, 2020
Nose Cells Found to Be Likely SARS-CoV-2 Entry Points
This work may help explain why the virus is so easy to transmit.
MAY 07, 2020
Cancer
MAY 07, 2020
Yet Another Cancer Linked Tyrosine Kinase
In a cell, there are tens of thousands of individual components. Each component has a specific activity or role that the ...
MAY 12, 2020
Chemistry & Physics
MAY 12, 2020
Improvised Face Covering: Finding Alternatives to Standard Masks During a Pandemic
On April 3rd, the US Centers for Disease Control and Prevention announced that they recommend members of the general pub ...
MAY 20, 2020
Cardiology
MAY 20, 2020
Hearts Beat Differently to Music
Does some music relax you, does other music excite you? There is a physiological response to music, and your heart may b ...
Loading Comments...